Á
Áron Bartha
Researcher at Semmelweis University
Publications - 7
Citations - 326
Áron Bartha is an academic researcher from Semmelweis University. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 2, co-authored 2 publications receiving 56 citations.
Papers
More filters
Journal ArticleDOI
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues.
Áron Bartha,Balázs Győrffy +1 more
TL;DR: In this article, the authors established an integrated database using available transcriptome-level datasets and created a web platform which enables the mining of this database by comparing normal, tumor and metastatic data across all genes in real time.
Journal ArticleDOI
Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology.
Áron Bartha,Balázs Győrffy +1 more
TL;DR: Analysis tools enabling utilization of WES data in clinical and research settings are reviewed, including its restricted ability to detect CNVs, low coverage compared to targeted sequencing, and the missing consensus regarding references and minimal application requirements.
Journal ArticleDOI
Emergency Use and Efficacy of an Asynchronous Teledermatology System as a Novel Tool for Early Diagnosis of Skin Cancer during the First Wave of COVID-19 Pandemic
A. Jobbágy,Norbert Kiss,F. Meznerics,K. Farkas,D. Plázár,Szabolcs Bozsányi,Luca Fésűs,Áron Bartha,Endre Szabó,Kende Lőrincz,Miklós Sárdy,Norbert Wikonkál,Péter Szoldán,András Bánvölgyi +13 more
TL;DR: Findings showed that asynchronous teledermatology using a mobile phone application served as an accurate skin cancer screening system during the first wave of the COVID-19 pandemic.
Journal ArticleDOI
In Vitro Insertional Mutagenesis Screen Identifies Novel Genes Driving Breast Cancer Metastasis.
Csaba Miskey,Lacramioara Botezatu,Nuri A. Temiz,Andreas Gogol-Doring,Áron Bartha,Balázs Győrffy,David A. Largaespada,Zoltán Ivics,Attila Sebe +8 more
TL;DR: Novel metastasis drivers were identified in a human breast cancer cell line by performing an in vitro, Sleeping Beauty transposon-based forward genetic screen and an RNA fusion-based candidate gene prediction.
Journal ArticleDOI
Proteotranscriptomic Discrimination of Tumor and Normal Tissues in Renal Cell Carcinoma
TL;DR: In this paper , the authors used a proteotranscriptomic approach to differentiate normal and tumor tissues in clear cell renal cell carcinoma (ccRCC) using transcriptomic data of patients with malignant and paired normal tissue samples from gene array cohorts.